Antibodies,

Antibodies, Vol. 8, Pages 41: Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells

Antibodies, Vol. 8, Pages 41: Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells Antibodies doi: 10.3390/antib8030041 Authors: Strohl Naso The concepts for T-cell redirecting bispecific antibodies (TRBAs) and chimeric antigen receptor (CAR)-T cells are both at least 30 years old but both platforms are just now coming into age. Two TRBAs and two CAR-T cell products have been approved by major regulatory agencies within...

Antibodies

Wed Jul 03, 2019 03:00

Antibodies, Vol. 8, Pages 40: Integrated Clarification and Purification of Monoclonal Antibodies by Membrane Based Separation of Aqueous Two-Phase Systems

Antibodies, Vol. 8, Pages 40: Integrated Clarification and Purification of Monoclonal Antibodies by Membrane Based Separation of Aqueous Two-Phase Systems Antibodies doi: 10.3390/antib8030040 Authors: Thomas Kruse Axel Schmidt Markus Kampmann Jochen Strube Therapeutic monoclonal antibodies (mAb) are used for the treatment of numerous serious diseases, which have led to an increasing demand over the last decades. Increased cell density and mAb titer of the cultivation broth lead...

Antibodies

Tue Jul 02, 2019 03:00